LBP and cancer: Several clinical trials and published studies have shown LBP’s antitumor activity in various cancer types, including breast cancer [4], colorectal cancer [5], hepatocellular carcinoma [6], small cell lung cancer [7], and melanoma [8], etc. Platinum-based dual-drug regimens are now standard first-line treatments for NSCLC.